RE: no supportGriz, I agree that management has scared people away. Not sure if it is ineptitude or just indifference to investors. It seems that BNC missing another target (i.e., Canadian approval of the E coli vaccine this summer) is just handled as "oh well, we'll just get it on the market next year". This seems to have been their story for the past 3 or 4 years.
If BNC knew last year that safety testing to evaluate an accidental human injection of the E coli vaccine was going to possibly required, why did they wait this long to commence the study? It's not a hard or expensive study to initiate, it just takes a while to complete.
If any of the above is inaccurate, BNC should articulate it as nothing drives investor outrage as being left in the dark.